Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by Mole101on Nov 16, 2021 1:15pm
143 Views
Post# 34132635

RE:RE:RE:Great Volume today

RE:RE:RE:Great Volume today

Mackie decided to buy today , Anon is the overall seller again . You can read it many ways , personally I see pressure and accumulation by some houses .We will
the last ones to know ...,


920,607 ($160,334) PMN.TO shares exchanged hands today.

House  Bought  Sold  Net 
House 083
Mackie
Bought $45,222
Volume 256,000
Average $0.177
Sold 0
Volume 0
Average 0
Net $45,222
Volume 256,000
 
House 009
BMO Nesbitt
Bought $43,480
Volume 256,500
Average $0.170
Sold $16,200
Volume 90,000
Average $0.180
Net $27,280
Volume 166,500
 
House 022
Fidelity
Bought $24,832
Volume 144,500
Average $0.172
Sold $1,750
Volume 10,000
Average $0.175
Net $23,082
Volume 134,500
 
House 080
National Bank
Bought $18,001
Volume 100,007
Average $0.180
Sold 0
Volume 0
Average 0
Net $18,001
Volume 100,007
 

JackRedwood wrote: Thanks Mole101

 

<< Previous
Bullboard Posts
Next >>